NuGen Medical Devices Inc., a specialty medical device company, develops and commercializes novel drug delivery technologies in Europe, Asia, North America, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, semaglutide, and growth and fertility hormone, as well as DNA and conventional/pediatric vaccines. It also provides InsuJet system that focuses on servicing the diabetic community; and V5, V6, V7, and V8 InsuJet injectors. NuGen Medical Devices Inc. is headquartered in Toronto, Canada.
Metrics to compare | NGMD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNGMDPeersSector | |
---|---|---|---|---|
P/E Ratio | −1.6x | −6.0x | −0.5x | |
PEG Ratio | −0.05 | −0.10 | 0.00 | |
Price / Book | −2.1x | 0.5x | 2.6x | |
Price / LTM Sales | 17.8x | 37.8x | 3.0x | |
Upside (Analyst Target) | - | 241.5% | 53.8% | |
Fair Value Upside | Unlock | −0.5% | 9.6% | Unlock |